NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for sponsors, patients, and sites across the clinical trial experience, welcomes the addition of Michelle Everill, VP, Global Trial Optimization...

The All-Hands Meeting highlights our commitment to excellence and innovation. With Session II completed, we're focused on empowering teams, improving communication, and advancing clinical research.”— Mazhar Jaffry, CEO, Prime Revival Research Institute, LLC NOVI, MICHIGAN,...

SAN FRANCISCO, Sept. 3, 2024 /PRNewswire/ -- Orchid, a reproductive technology company offering the world's only commercially available whole genome embryo screening, is thrilled to announce the appointment of Dr. Funda Suer as its new executive president and medical...

Distinctive Asset Type Asset Type Usage - Asset Type Meta Analysis Prioritisation - Average Asset Score By Ranking Reach & Frequency - Brand Distinctiveness Score X Brand Familiarity New research by Distinctive BAT highlights the key factors that...

HOUSTON, Sept. 3, 2024 /PRNewswire/ -- Empower Pharmacy, the country's most advanced compounding pharmacy in Houston, and Empower Pharma, outsourcing facilities in Texas and New Jersey, have announced the appointment of Bob Irwin as President. Founder Shaun Noorian will...

Investment Re-Affirms Presence and Conviction in Midtown Atlanta Market SAN FRANCISCO, July 24, 2024 /PRNewswire/ -- Shorenstein Investment Advisers ("Shorenstein"), an owner and operator of high-quality office, residential and mixed-use properties across the U.S., today announced its acquisition of 14th...